Results 51 to 60 of about 24,654 (177)
A guide to transcriptional cyclin‐dependent kinases in cancer
Transcriptional cyclin‐dependent‐kinases (tCDKs) facilitate gene expression by promoting RNA polymerase II (RNAPII) progression through discrete phases of the transcription cycle. Aberrant tCDK activity is detectable in different human cancers, thereby contributing to de‐regulated gene expression programs that drive oncogenic phenotypes.
Jennifer R. Devlin +2 more
wiley +1 more source
BACKGROUND AND OBJECTIVES: We previously described a novel type of the chimeric bcr-abl mRNA transcript in a patient with a Philadelphia chromosome positive chronic myeloid leukemia. A similar bcr-abl transcript has also been described by others.
G Martinelli +8 more
doaj
Atypical BCR-ABL mRNA transcripts in adult Acute lymphoblastic leukemia
RT-PCR detects chimeric BCR-ABL mRNA in approximately 25% of adult acute lymphoblastic leukemia (ALL) cases. Minor breakpoint transcripts (e1a2) are found in about 70% of positive cases and major breakpoint transcripts (e13a2, e14a2) in about 30% of ...
Thomas Burmeister +13 more
doaj +1 more source
Delayed Gastric Bleeding in a Patient With Chronic Myeloid Leukemia: A Case of Post‐Biopsy Bleeding
The presence of underlying conditions, particularly malignancies such as myeloproliferative disorders, may increase the risk of delayed bleeding following gastric mucosal biopsy, and similar cases warrant careful accumulation and evaluation in future. ABSTRACT A 76‐year‐old man was referred to our hospital for evaluation of anemia.
Yoko Kosaka +3 more
wiley +1 more source
The mechanisms of taxodione-induced apoptosis in BCR-ABL-positive leukemia cells
Chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) are caused by a fusion protein, BCR-ABL, which induces cellular transformation by activating the signaling molecules, STAT5 and Akt. The specific BCR-ABL inhibitors including imatinib, nilotinib, and dasatinib, are clinically utilized in the treatment with CML and ALL patients ...
Yuki, Uchihara +2 more
openaire +3 more sources
Extreme Thrombocytosis in Patients With Malignancy; Complications, Management and Outcomes
ABSTRACT Introduction Extreme thrombocytosis (EXT; platelet count >1000 × 109/L) is a rare haematological abnormality that may be primary or reactive. Data on its incidence and management in patients with malignancy are limited. We retrospectively evaluated the incidence, management, and complications of EXT in patients with malignancy over a 12‐year ...
Laura McDonald +8 more
wiley +1 more source
Quinacrine Depletes BCR-ABL and Suppresses Ph-Positive Leukemia Cells
Drug resistance to TKIs and the existance of CML leukemia stem cells is an urgent problem. In this study, we demonstrate that quinacrine (QC) induces apoptosis in BCR-ABL positive CML and acute lymphoblastic leukemia (ALL) cells. Interestingly, QC inhibits the colony formation of primary CD34+ progenitor/stem leukemia cells from CML patients.
Hu Lei +8 more
openaire +2 more sources
Abstract Accurate modeling of synthetic protein–protein interactions is essential for designing therapeutics, diagnostics, and molecular imaging reagents. Although deep learning has transformed protein structure prediction, modeling heteromeric interactions mediated by flexible loops—as in antibodies, nanobodies, and monobodies—remains challenging due ...
Lourdes Carcelén +2 more
wiley +1 more source
Overcoming chemoresistance in gastric cancer by targeting TLR2. ABSTRACT Chemoresistance remains a major barrier to effective treatment of gastric cancer (GC), particularly in advanced disease, where cytotoxic chemotherapy often yields limited and transient responses.
Kuanheng Zheng +6 more
wiley +1 more source

